查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1750865

基于 CRISPR 的诊断市场规模、份额、趋势分析报告：按产品、技术、应用、最终用途、地区、细分市场预测，2025 年至 2030 年

CRISPR-Based Diagnostics Market Size, Share & Trends Analysis Report By Product (Enzymes, Kits & Reagents, Software & Libraries), By Technology (Cas9, Cas12), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

基于 CRISPR 的诊断市场成长和趋势

根据 Grand View Research, Inc 的最新报告，全球基于 CRISPR 的诊断市场规模预计到 2030 年将达到 75.5 亿美元，2025-2030 年期间的复合年增长率为 16.57%。

技术创新对于推动基于 CRISPR 的诊断市场发展至关重要。 Cas12 和 Cas13 等新型 Cas 酶的开发提高了基于 CRISPR 的诊断检测的敏感度和特异性。这些进步正在促进快速照护现场诊断工具的开发，这些工具可以高精度地检测病原体和基因突变。 2023 年 8 月，印度生技新兴企业CrisprBits 与 Molbio Diagnostics 合作开发了一款基于 CRISPR 的即时诊断检测。这项合作促成了 PathCrisp 平台的创建，该平台旨在快速准确地检测疾病，有助于在资源有限的环境中扩大 CRISPR 诊断的可用性。这类合作展现了技术进步如何转化为实用的诊断解决方案。

市场规模的激增源于医疗支出的增加、基因编辑技术需求的不断增长以及慢性病和遗传疾病的流行等因素。例如，世界卫生组织 (WHO) 报告称，2024 年结核病仍将是全球第二大常见感染疾病，预计 2023 年将有 1,080 万人被诊断出患有结核病。这些数据凸显了对基于 CRISPR 的检测等先进诊断工具的迫切需求。

全球遗传感染疾病的盛行率不断上升，对先进诊断工具的需求也随之增加。根据国际癌症研究机构的数据，预计全球新增癌症病例数将从 2025 年的 2,130 万增加到 2050 年的 3,530 万人。同样，2024 年 8 月《柳叶刀》杂誌发表的一项研究显示，非欧洲人群中囊肿纤维化的盛行率高于预期，尤其是在印度半岛。这种趋势凸显了对精确快速诊断方法的需求，例如基于 CRISPR 的测试，以便能够及早发现和治疗各种疾病。 CRISPR 诊断能够准确识别特定基因序列，对于解决日益加重的遗传感染疾病负担具有不可估量的价值。

从区域来看，基于 CRISPR 的诊断市场呈现多种成长模式。由于感染疾病的高发性和医疗基础设施投资的不断增加，亚太地区目前占据最大的市场占有率。同时，由于强劲的研发投入和对先进诊断技术的早期采用，北美预计将成为成长最快的地区。例如，2023 年 9 月，Sherlock Biosciences 获得了比尔和梅琳达盖兹基金会的额外资助，以加强其利用 CRISPR 技术进行快速、无需仪器的分子诊断技术检测人类乳突病毒 (HPV) 的开发。这些倡议反映了该地区利用 CRISPR 技术解决公共卫生挑战的努力。

CRISPR诊断市场报告重点

  • 从产品来看，受CRISPR检测系统在临床和研究领域的广泛应用所推动，套件和试剂将在2024年引领市场，占据最大的收入份额。全球对照护现场诊断（尤其是感染疾病和遗传疾病）的需求不断增长，推动了对即用型诊断试剂套件和高品质试剂的需求。
  • 从技术角度来看，Cas9凭藉其在CRISPR技术发展中发挥的重要作用，在2024年占据了主导市场占有率。作为第一个也是研究最广泛的CRISPR相关蛋白，Cas9有助于实现精准的DNA标靶化和切割，使其成为基因诊断的首选工具。
  • 从应用角度来看，由于全球迫切需要快速、准确且可扩展的检测解决方案，因此因此预计感染疾病诊断将在2024年占据最大的市场占有率。 CRISPR技术，尤其是基于Cas12和Cas13的技术，能够透过精确识别核酸序列，实现对病毒和细菌病原体的高度灵敏检测。
  • 目前，爱滋病毒、肝炎、结核病和呼吸道感染疾病等需要准确及时诊断的感染疾病疫情日益猖獗。
  • 由于慢性病和感染疾病的流行、人们对个人化医疗的兴趣日益浓厚、研发支出高昂以及就地检验的进步，北美在 2024 年占据了全球市场的最大收入份额。

目录

第一章调查方法与范围

第二章执行摘要

3. 基于 CRISPR 的诊断市场变数、趋势和范围

  • 市场介绍/电网展望
  • 市场规模和成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 基于CRISPR的诊断市场分析工具
    • 波特分析
    • PESTEL分析

4. CRISPR 诊断市场（按产品、估值和趋势分析）

  • 细分仪表板
  • CRISPR 诊断市场：2024 年和 2030 年产品差异分析
  • 酵素
  • 套件和试剂
  • 软体和函式库

5. CRISPR 诊断市场（按技术、估值和趋势分析）

  • 细分仪表板
  • CRISPR 诊断市场：2024 年和 2030 年技术变革分析
  • Cas9
  • Cas12
  • 其他的

6. CRISPR 诊断市场的应用、预测与趋势分析

  • 细分仪表板
  • CRISPR 诊断市场：应用变化分析，2024 年和 2030 年
  • 感染疾病诊断
  • 遗传疾病诊断
  • 癌症诊断
  • 其他的

7. CRISPR 诊断市场（按最终用途、估值和趋势分析）

  • 细分仪表板
  • CRISPR 诊断市场：最终用途变异分析，2024 年和 2030 年
  • 医院和诊所的诊断
  • 研究所
  • 製药和生物技术公司
  • 其他的

8. CRISPR 诊断市场（按地区划分）、估值及趋势分析

  • 2024 年及 2030 年 CRISPR 诊断市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司分类
  • 公司热图分析
  • 公司简介
    • Thermo Fisher Scientific Inc.
    • Integrated DNA Technologies, Inc.
    • Molbio Diagnostics
    • Horizon Discovery
    • Synthego Corporation
    • Mammoth Biosciences
    • Sherlock Biosciences
    • Caribou Biosciences
    • CrisprBits
    • ToolGen Inc.
Product Code: GVR-4-68040-572-1

CRISPR-based Diagnostics Market Growth & Trends:

The global CRISPR-based diagnostics market size is expected to reach USD 7.55 billion by 2030, registering a CAGR of 16.57% from 2025 to 2030, according to a new report by Grand View Research, Inc. Technological innovations have been pivotal in propelling the CRISPR diagnostics market forward. The development of novel Cas enzymes, such as Cas12 and Cas13, has enhanced the sensitivity and specificity of CRISPR-based diagnostic tests. These advancements have facilitated the creation of rapid, point-of-care (POC) diagnostic tools capable of detecting pathogens and genetic mutations with high accuracy. In August 2023, Indian biotech startup CrisprBits collaborated with Molbio Diagnostics to develop CRISPR-based POC tests. This partnership led to the creation of the PathCrisp platform, designed for rapid and precise disease detection, and has been instrumental in expanding the availability of CRISPR diagnostics in resource-limited settings. Such collaborations exemplify how technological advancements are translating into practical diagnostic solutions.

The surge in market size is attributed to factors such as increased healthcare spending, heightened demand for gene editing technologies, and a growing prevalence of chronic and genetic diseases. For instance, the World Health Organization reported in 2024 that tuberculosis (TB) remained the second most common infectious disease worldwide, with an estimated 10.8 million people diagnosed in 2023 Such statistics underscore the pressing need for advanced diagnostic tools such as CRISPR-based tests.

The increasing incidence of genetic disorders and infectious diseases globally has amplified the demand for advanced diagnostic tools. According to the International Agency for Research on Cancer, the number of new cancer cases worldwide is expected to rise from 21.3 million in 2025 to 35.3 million by 2050. Similarly, research published in The Lancet in August 2024 highlighted a higher-than-expected prevalence of cystic fibrosis in non-European populations, particularly in the Indian subcontinent. These trends underscore the necessity for precise and rapid diagnostic methods, such as CRISPR-based tests, which can facilitate early detection and treatment of various diseases. The ability of CRISPR diagnostics to accurately identify specific genetic sequences makes them invaluable in managing the growing burden of genetic and infectious diseases.

Geographically, the CRISPR diagnostics market exhibits varying growth patterns. Asia Pacific currently holds the largest market share, driven by a high prevalence of infectious diseases and increasing investments in healthcare infrastructure. Conversely, North America is projected to be the fastest-growing region, attributed to substantial research and development investments and early adoption of advanced diagnostic technologies. For instance, in September 2023, Sherlock Biosciences received additional funding from the Bill & Melinda Gates Foundation to enhance the development of rapid, instrument-free molecular diagnostics leveraging CRISPR technology for Human Papillomavirus (HPV) detection . Such initiatives reflect the regional efforts to harness CRISPR technology in addressing public health challenges.

CRISPR-based Diagnostics Market Report Highlights:

  • In 2024, kits and reagents led the market with a largest revenue share, driven by the widespread deployment of CRISPR-based detection systems in both clinical and research settings. The increasing global demand for point-of-care diagnostics, particularly for infectious and genetic diseases, has amplified the need for ready-to-use diagnostic kits and high-quality reagents.
  • The Cas9 segment secured the dominant market share in 2024, due to its foundational role in the development of CRISPR technologies. As the first and most widely studied CRISPR-associated protein, Cas9 has been instrumental in enabling precise DNA targeting and cleavage, making it a preferred tool for genetic diagnostics
  • The infectious disease diagnostics held the largest market share in 2024, driven by the urgent global need for rapid, accurate, and scalable testing solutions. CRISPR technologies, particularly those leveraging Cas12 and Cas13, enable highly sensitive detection of viral and bacterial pathogens by identifying nucleic acid sequences with precision.
  • Pharmaceutical and biotechnology companies held the dominant market share in 2024 and is expected to be the fastest-growing segment over the forecast period. driven by the rising prevalence of infectious diseases such as HIV, hepatitis, tuberculosis, and respiratory infections, which require accurate and timely diagnosis.
  • North America dominated the global market with the largest revenue share in 2024, driven by a high burden of chronic and infectious diseases, a growing focus on personalized medicine, substantial R&D spending, and advances in point-of-care testing.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. CRISPR-Based Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. CRISPR-Based Diagnostics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. CRISPR-Based Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. CRISPR-Based Diagnostics Market: Product Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Enzymes
    • 4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Kits and Reagents
    • 4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Software and Libraries
    • 4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. CRISPR-Based Diagnostics Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. CRISPR-Based Diagnostics Market: Technology Movement Analysis, USD Million, 2024 & 2030
  • 5.3. Cas9
    • 5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Cas12
    • 5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. CRISPR-Based Diagnostics Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. CRISPR-Based Diagnostics Market: Application Movement Analysis, USD Million, 2024 & 2030
  • 6.3. Infectious Disease Diagnostics
    • 6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Genetic Disorder Diagnostics
    • 6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Cancer Diagnostics
    • 6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. CRISPR-Based Diagnostics Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. CRISPR-Based Diagnostics Market: End Use Movement Analysis, USD Million, 2024 & 2030
  • 7.3. Hospitals and Clinics Diagnostic
    • 7.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Laboratories
    • 7.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Pharmaceutical and Biotechnology Companies
    • 7.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. CRISPR-Based Diagnostics Market: Regional Estimates & Trend Analysis

  • 8.1. CRISPR-Based Diagnostics Market Share, By Region, 2024 & 2030 ( USD Million)
  • 8.2. North America
    • 8.2.1. North America CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. France CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Italy CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Spain CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Norway CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. China CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Australia CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. South Korea
      • 8.4.6.1. South Korea CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. South Africa CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. UAE CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific Inc.
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/ Strategic Initiatives
    • 9.4.2. Integrated DNA Technologies, Inc.
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/ Strategic Initiatives
    • 9.4.3. Molbio Diagnostics
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/ Strategic Initiatives
    • 9.4.4. Horizon Discovery
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/ Strategic Initiatives
    • 9.4.5. Synthego Corporation
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/ Strategic Initiatives
    • 9.4.6. Mammoth Biosciences
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/ Strategic Initiatives
    • 9.4.7. Sherlock Biosciences
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/ Strategic Initiatives
    • 9.4.8. Caribou Biosciences
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/ Strategic Initiatives
    • 9.4.9. CrisprBits
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/ Strategic Initiatives
    • 9.4.10. ToolGen Inc.
      • 9.4.10.1. Participant's Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global CRISPR-based diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 5 Global CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 North America CRISPR-based diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 10 North America CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 U.S. CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 13 U.S. CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 14 U.S. CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 15 U.S. CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Canada CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 17 Canada CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Canada CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 19 Canada CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Mexico CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 21 Mexico CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Mexico CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 23 Mexico CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Europe CRISPR-based diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 25 Europe CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 26 Europe CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Europe CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 28 Europe CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 UK CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 30 UK CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 31 UK CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 32 UK CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Germany CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 34 Germany CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 35 Germany CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 36 Germany CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 France CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 38 France CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 39 France CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 40 France CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Italy CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 42 Italy CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Italy CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 44 Italy CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Spain CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 46 Spain CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Spain CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 48 Spain CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Denmark CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 50 Denmark CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 51 Denmark CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 52 Denmark CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Sweden CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 54 Sweden CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 55 Sweden CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 56 Sweden CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Norway CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 58 Norway CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 59 Norway CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 60 Norway CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific CRISPR-based diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Japan CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 67 Japan CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Japan CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 69 Japan CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 China CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 71 China CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 72 China CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 73 China CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 India CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 75 India CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 76 India CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 77 India CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 Australia CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 79 Australia CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 80 Australia CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 81 Australia CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 South Korea CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 83 South Korea CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 84 South Korea CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Korea CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 Thailand CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 87 Thailand CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 88 Thailand CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 89 Thailand CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 Latin America CRISPR-based diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 91 Latin America CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 92 Latin America CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 93 Latin America CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 94 Latin America CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 95 Brazil CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 96 Brazil CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 97 Brazil CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 98 Brazil CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 99 Argentina CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 100 Argentina CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 101 Argentina CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 102 Argentina CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 103 MEA CRISPR-based diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 104 MEA CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 105 MEA CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 106 MEA CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 107 MEA CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 108 South Africa CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 109 South Africa CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 110 South Africa CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Africa CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 116 UAE CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 117 UAE CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 118 UAE CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 119 UAE CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)
  • Table 120 Kuwait CRISPR-based diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 121 Kuwait CRISPR-based diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 122 Kuwait CRISPR-based diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait CRISPR-based diagnostics market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 CRISPR-based diagnostics market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 CRISPR-based diagnostics market: Product outlook key takeaways
  • Fig. 20 CRISPR-based diagnostics market: Product movement analysis
  • Fig. 21 Transfemoral market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Enzymes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Kits and Reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Software and libraries market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 CRISPR-based diagnostics market: Technology outlook key takeaways
  • Fig. 26 CRISPR-based diagnostics market: Technology movement analysis
  • Fig. 27 Cas9 market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Cas12 market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 CRISPR-based diagnostics market: Application outlook key takeaways
  • Fig. 31 CRISPR-based diagnostics market: Application movement analysis
  • Fig. 32 Infectious disease diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Genetic disorder diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Cancer diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 CRISPR-based diagnostics market: End-use outlook key takeaways
  • Fig. 37 CRISPR-based diagnostics market: End-use movement analysis
  • Fig. 38 Hospitals and clinics diagnostic market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Pharmaceutical and biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Regional marketplace outlook, 2024 & 2030 (USD Million)
  • Fig. 43 Regional marketplace: Key takeaways
  • Fig. 44 North America CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 U.S. CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Canada CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Mexico CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Europe CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 UK CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Germany CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 France CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Spain CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Italy CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Denmark CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Sweden CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Norway CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Asia Pacific CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Japan CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 China CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 India CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Australia CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 South Korea CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Thailand CRISPR-based diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Market participant categorization
  • Fig. 83 CRISPR-based diagnostics market position analysis, 2024
  • Fig. 84 Strategic framework